Terms: = Leukemia AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Treatment
255 results:
1. Discovery of a Novel Orally Bioavailable FLT3-PROTAC Degrader for Efficient treatment of Acute Myeloid leukemia and Overcoming Resistance of FLT3 Inhibitors.
Wang J; Rong Q; Ye L; Fang B; Zhao Y; Sun Y; Zhou H; Wang D; He J; Cui Z; Zhang Q; Kang D; Hu L
J Med Chem; 2024 May; 67(9):7197-7223. PubMed ID: 38655686
[TBL] [Abstract] [Full Text] [Related]
2. Single-cell sequencing unveils T-cell characteristic in acute myeloid leukemia.
Zhu G; Lang W; Fu W; Xu L; Cai J; Zhong H
Int Immunopharmacol; 2024 May; 132():111927. PubMed ID: 38555820
[TBL] [Abstract] [Full Text] [Related]
3. Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax.
Li D; Yuan Y; Meng C; Lin Z; Zhao M; Shi L; Li M; Ye D; Cai Y; He X; Ye H; Zhou S; Zhou H; Gao S
Clin Epigenetics; 2024 Mar; 16(1):48. PubMed ID: 38528641
[TBL] [Abstract] [Full Text] [Related]
4. The influence of cytotoxic drugs on the immunophenotype of blast cells in paediatric B precursor acute lymphoblastic leukaemia.
Prelog T; Bucek S; Brozic A; Peterlin J; Kavcic M; Omerzel M; Markelc B; Jesenko T; Prevodnik VK
Radiol Oncol; 2024 Mar; 58(1):133-144. PubMed ID: 38378030
[TBL] [Abstract] [Full Text] [Related]
5. Licochalcone A induces mitochondria-dependent apoptosis and interacts with venetoclax in acute myeloid leukemia.
Li Y; Zhao M; Lin Y; Jiang X; Jin L; Ye P; Lu Y; Pei R; Jiang L
Eur J Pharmacol; 2024 Apr; 968():176418. PubMed ID: 38350590
[TBL] [Abstract] [Full Text] [Related]
6. CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.
Buldini B; Varotto E; Maurer-Granofszky M; Gaipa G; Schumich A; Brüggemann M; Mejstrikova E; Cazzaniga G; Hrusak O; Szczepanowski M; Scarparo P; Zimmermann M; Strehl S; Schinnerl D; Zaliova M; Karawajew L; Bourquin JP; Feuerstein T; Cario G; Alten J; Möricke A; Biffi A; Parasole R; Fagioli F; Valsecchi MG; Biondi A; Locatelli F; Attarbaschi A; Schrappe M; Conter V; Basso G; Dworzak MN
Blood; 2024 Apr; 143(17):1738-1751. PubMed ID: 38215390
[TBL] [Abstract] [Full Text] [Related]
7. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
Shumilov E; Mazzeo P; Ghandili S; Künstner A; Weidemann S; Banz Y; Ströbel P; Pollak M; Kolloch L; Beltraminelli H; Kerkhoff A; Mikesch JH; Schliemann C; Haase D; Wulf G; Legros M; Lenz G; Feldmeyer L; Pabst T; Witte H; Gebauer N; Bacher U
Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088
[TBL] [Abstract] [Full Text] [Related]
8. Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cells.
Vogt M; Dienstbier N; Schliehe-Diecks J; Scharov K; Tu JW; Gebing P; Hogenkamp J; Bilen BS; Furlan S; Picard D; Remke M; Yasin L; Bickel D; Kalia M; Iacoangeli A; Lenz T; Stühler K; Pandyra AA; Hauer J; Fischer U; Wagener R; Borkhardt A; Bhatia S
Cell Death Dis; 2023 Dec; 14(12):799. PubMed ID: 38057328
[TBL] [Abstract] [Full Text] [Related]
9. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
10. cd45 inhibition in myeloid leukaemia cells sensitizes cellular responsiveness to chemotherapy.
Al Barashdi MAS; Ali A; McMullin MF; Mills K
Ann Hematol; 2024 Jan; 103(1):73-88. PubMed ID: 37917373
[TBL] [Abstract] [Full Text] [Related]
11. Flow cytometric signature of CD371-positive B-cell acute lymphoblastic leukemia.
Shakah H; Tbakhi A; Khudirat S; Abweh RA; Hasasna N; Alwhaidi A; Khoujah A; Barakat F
J Int Med Res; 2023 Oct; 51(10):3000605231203842. PubMed ID: 37818740
[TBL] [Abstract] [Full Text] [Related]
12. Epitope base editing cd45 in hematopoietic cells enables universal blood cancer immune therapy.
Wellhausen N; O'Connell RP; Lesch S; Engel NW; Rennels AK; Gonzales D; Herbst F; Young RM; Garcia KC; Weiner D; June CH; Gill SI
Sci Transl Med; 2023 Sep; 15(714):eadi1145. PubMed ID: 37651540
[TBL] [Abstract] [Full Text] [Related]
13. The shape of cancer relapse: Topological data analysis predicts recurrence in paediatric acute lymphoblastic leukaemia.
Chulián S; Stolz BJ; Martínez-Rubio Á; Blázquez Goñi C; Rodríguez Gutiérrez JF; Caballero Velázquez T; Molinos Quintana Á; Ramírez Orellana M; Castillo Robleda A; Fuster Soler JL; Minguela Puras A; Martínez Sánchez MV; Rosa M; Pérez-García VM; Byrne HM
PLoS Comput Biol; 2023 Aug; 19(8):e1011329. PubMed ID: 37578973
[TBL] [Abstract] [Full Text] [Related]
14. Clinical and Laboratory Characteristics of IgM Primary Plasma Cell leukemia.
Wu Y; Zhang X; Ma X; Suo X; Li R
Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436385
[TBL] [Abstract] [Full Text] [Related]
15. Theranostics in Hematooncology.
Buck AK; Serfling SE; Kraus S; Samnick S; Dreher N; Higuchi T; Rasche L; Einsele H; Werner RA
J Nucl Med; 2023 Jul; 64(7):1009-1016. PubMed ID: 37290799
[TBL] [Abstract] [Full Text] [Related]
16. In vivo activity of the dual PI3Kδ and PI3Kγ inhibitor duvelisib against pediatric acute lymphoblastic leukemia xenografts.
Randall J; Evans K; Watts B; Smith CM; Hughes K; Earley EJ; Erickson SW; Pachter JA; Teicher BA; Smith MA; Lock RB
Pediatr Blood Cancer; 2023 Aug; 70(8):e30398. PubMed ID: 37140091
[TBL] [Abstract] [Full Text] [Related]
17. Acute myeloid leukemia with RAM immunophenotype: A new underdiagnosed entity.
Gajendra S; Anupurba S; Gupta R; Mallick S; Panda D; Thakral D; Gupta SK; Bakhshi S; Seth R; Rai S; Prajapati VK; Singh S
Int J Lab Hematol; 2023 Aug; 45(4):541-552. PubMed ID: 37078511
[TBL] [Abstract] [Full Text] [Related]
18. De novo myeloid sarcoma mimicking gynecological tumors: a retrospective case series of eight patients.
Gu Y; Zheng H; Mo S; Guo T; Chen L; Yang J; Xiang Y
BMC Womens Health; 2023 Mar; 23(1):141. PubMed ID: 36978050
[TBL] [Abstract] [Full Text] [Related]
19. Rare Pattern of Myelodysplastic Syndrome (MDS) with Serum Monoclonal Immunoglobulin: Case Report.
Lin Y; He J; Li F; Gu X
Altern Ther Health Med; 2023 Apr; 29(3):266-270. PubMed ID: 36735715
[TBL] [Abstract] [Full Text] [Related]
20. Intraoral myeloid sarcoma presenting as toothache and gingival mass.
Sedeta E; Pokhrel A; Nair K; Gotlieb V
BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36593620
[TBL] [Abstract] [Full Text] [Related]
[Next]
